1. Early Virologic Responses and Hematologic Safety of Direct-Acting Antiviral Therapies in Veterans With Chronic Hepatitis C 
Pamela S. Belperio, Elizabeth W. Hwang, I. Chun Thomas, Larry A. Mole, Ramsey C. Cheung, Lisa I. Backus 
Clinical Gastroenterology and Hepatology 
Volume 11, Issue 8, Pages (August 2013)
DOI: /j.cgh
Copyright © 2013 AGA Institute Terms and Conditions

2. Figure 1 Boceprevir and telaprevir on-treatment rates over time.
Clinical Gastroenterology and Hepatology  , DOI: ( /j.cgh )
Copyright © 2013 AGA Institute Terms and Conditions

3. Figure 2
Futility and treatment discontinuation up to week 24 in patients treated with pegylated interferon/ribavirin and either boceprevir or telaprevir: (A) boceprevir, and (B) telaprevir.
Clinical Gastroenterology and Hepatology  , DOI: ( /j.cgh )
Copyright © 2013 AGA Institute Terms and Conditions